1.
Record response to call for new astronauts
NEW YORK, July 31 (UPI) -- Maryland-based Medimmune pharmaceuticals expects to produce nearly five times the amount of H1N1 vaccine originally anticipated, its executives said.
Medimmune, a subsidiary of AstraZeneca, expects to make 200 million doses by March, so many doses it will run out of nasal spray devices and may have to use nose droppers, Bernardus N.M. Machielse, Medimmune's executive vice president for operations told The New York Times.
Medimmune is of the five companies under contract to the U.S. government to produce H1N1 flu vaccine. Medimmune also makes the nasal spray vaccine FluMist for seasonal flu viruses.
An H1N1 nasal spray vaccine could be a strong weapon against swine flu because makers of conventional flu shots have reported problems producing their vaccines, the Times reported.
So far, the U.S. government has ordered 12.8 million doses of H1N1 vaccine from Medimmune for $151 million and could order millions more doses, federal officials told the Times.
|
|
|
| Additional Science News Stories | |
WASHINGTON, Feb. 9 (UPI) --
The late Steve Jobs, co-founder of the U.S. computer giant Apple, had faults in his personal life but was a business visionary, associates told the FBI.
|
NEW YORK, Feb. 9 (UPI) --
Macaulay Culkin is in "perfectly good health," his publicist said after the former child star was photographed looking gaunt and disheveled in New York.
|
GREENBELT, Md., Feb. 9 (UPI) --
NASA's Mars Reconnaissance Orbiter has captured the first color image from orbit of the three-petal lander of NASA's 2004 Rover Spirit mission, scientists say.
|
ASHLAND, Mass., Feb. 9 (UPI) --
An Ashland, Mass., driver was arrested and charged for throwing a handful of pennies at another car, police said.
|
| Stories | Photos | People | Comments |
View Caption
